Tirzepatide 5 mg is a prescription injectable medicine that acts as a dual GIP and GLP-1 receptor agonist. It is used for the management of type 2 diabetes and, depending on the specific product and local approval, may also be prescribed for chronic weight management. 🇬🇧 UK Tirzepatide 5 mg UK tirzepatide 5 mg injection UK tirzepatide injection UK tirzepatide prefilled pen UK tirzepatide for type 2 diabetes UK tirzepatide weight management UK GIP GLP-1 receptor agonist UK tirzepatide medication UK 🇺🇸 USA Tirzepatide 5 mg USA tirzepatide 5 mg injection USA tirzepatide injection USA tirzepatide prefilled pen USA tirzepatide for type 2 diabetes USA tirzepatide weight management USA GIP GLP-1 receptor agonist USA tirzepatide medication USA 🇨🇦 Canada Tirzepatide 5 mg Canada tirzepatide 5 mg injection Canada tirzepatide injection Canada tirzepatide prefilled pen Canada tirzepatide for type 2 diabetes Canada tirzepatide weight management Canada GIP GLP-1 receptor agonist Canada tirzepatide medication Canada 🇮🇳 India Tirzepatide 5 mg India tirzepatide 5 mg injection India tirzepatide injection India tirzepatide prefilled pen India tirzepatide for type 2 diabetes India tirzepatide weight management India GIP GLP-1 receptor agonist India tirzepatide medication India 🇦🇺 Australia Tirzepatide 5 mg Australia tirzepatide 5 mg injection Australia tirzepatide injection Australia tirzepatide prefilled pen Australia tirzepatide for type 2 diabetes Australia tirzepatide weight management Australia GIP GLP-1 receptor agonist Australia tirzepatide medication Australia 🇰🇷 South Korea Tirzepatide 5 mg South Korea tirzepatide 5 mg injection South Korea tirzepatide injection South Korea tirzepatide prefilled pen South Korea tirzepatide for type 2 diabetes South Korea tirzepatide weight management South Korea GIP GLP-1 receptor agonist South Korea tirzepatide medication South Korea 🇸🇬 Singapore Tirzepatide 5 mg Singapore tirzepatide 5 mg injection Singapore tirzepatide injection Singapore tirzepatide prefilled pen Singapore tirzepatide for type 2 diabetes Singapore tirzepatide weight management Singapore GIP GLP-1 receptor agonist Singapore tirzepatide medication Singapore